본문영역
|
나노바이오융합연구센터 세미나 - Tracing the origin of disease with cutting-edge technology
작성자 : 관리자작성일 :2013-09-26 09:50:04조회수 : 3457
: 행사공지
|
|||||||
|---|---|---|---|---|---|---|---|
<Tracing the origin of disease with cutting-edge technology>일정 : 2013. 09. 26(목) 16:00 ~ 17:00
장소 : 융기원 A동 세미나룸 IV
연사 : 최진우 교수
- Assistant Professor in Wonkwang University
- Visiting Research Scientist in Harvard Medical School
- 2003 B.S SungKyunKwan University, Department of Genetic Engineering
- 2009 Ph.D Seoul National University, College of Pharmacy, Department of Bio-medicinal science
- Feb 2003~Aug 2003 : Assistant Researcher (The Research Institute of Pharmaceutical Science, Seoul )
- Mar 2007~Aug 2009 : Research Consultant ( R&D center, Neomics. Co. Ltd.)
- Sep 2009~Aug 2010 : Senior Scientist (R&D center , Neomics. Co.Ltd.)
- Sep 2010~ Present : Advisory Committee member (Department of Biotech Industry, Law Firm ShinWoo)
- Sep 2010~ Present : Research Fellow / Post doctoral Course (Harvard Medical School / Massachusetts General Hospital)
- Sep 2011~ Mar 2012 Research Associate (Flateley Lab, Boston, MA)
- Sep 2011~ Present Joint Research Associate (Physical Science-Oncology Center, NIH, US)
초록 : As for the coverage from cancer to neurodegenerative disease, recent non-invasive in vivo imaging and bioinformatics method will be introduced in this presentation. Utilizing those two potent techniques, the origin of disease has been traced with regards to cancer stem cell and drug resistant cell.
Small animal, particularly mouse, has been an important test bed for basic and translational biomedical study preceding clinical application. Recent technical advance has produced animal models to mimic human disease with genetically encoded or externally tagged biomarkers. Combined with well-designed endoscopic probes, it has led us see a new avenue to investigate complex pathophysiology of human disease such as neurodegeration and cancer, in animal model at cellular and molecular level.
On the other hand, recent development of various algorithms has been bringing the opportunity to get great genomic knowledge at a time. ARACNe and Connectivity Map are the most useful tools among them. The former was initially applied to classification of glioblastoma aggressiveness and the latter was only to establish tripartite relationship among genes, chemicals and diseases. Through them, transcription factors and chemicals to overcome chemoresistance were analyzed. They seems to be pretty reproducible in vitro and in vivo.
Additionally, other integrative technology like optogenetics and PDT will be also briefly introduced in this talk.
초청자 : 차세대융합기술연구원 나노바이오융합연구센터 송윤규 센터장 (031-888-9133, 010-6416-9040, songyk@snu.ac.kr)
|
|||||||
| 영상주소 | |||||||
| 이전글 | [채용공고]홍보업무분야 모집 (신입 또는 경력) 2013-09-24 |
|---|---|
| 현재글 | 나노바이오융합연구센터 세미나 - Tracing the origin of disease with cutting-edge technology 2013-09-26 |
| 다음글 | [연구비] 융기원 연구비 관련 지침 및 연구비 신청 양식 2013-10-04 |
